Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Compositions and methods for the diagnosis and treatment of ovarian cancers that are associated with reduced SMARCA4 gene expression or protein function

US Patent 11441190 · Granted Sep 13, 2022

Assignee

Inventors

View full patent text on Google Patents →